SurViva joins Oslo Cancer Cluster
SurViva is a Norwegian consultancy providing quality guidance for life science companies.
New research on genetic risk and breast cancer
New Norwegian research in polygenic risk score
A roadmap for the health industry
What is the government’s ambition for the health industry?
Personalised medicine to relieve the health service
Smaller patient groups and targeted treatments are the future of cancer care in Norway. It is no longer a question of if but when personalised medicine will be a reality for all cancer patients in Norway. This was a key message in a recent meeting arranged by the public-private consortium CONNECT during Arendalsuka, where the […]
Arendalsuka: – We need to attract the big companies
How will Norway implement the Mission on Cancer?
Arendalsuka 2023
Møt oss i Arendal! Vi snakker om kreftinnovasjon med politikerne.
